ciprofloxacin has been researched along with carbamazepine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.41) | 18.2507 |
2000's | 4 (14.81) | 29.6817 |
2010's | 16 (59.26) | 24.3611 |
2020's | 5 (18.52) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Avdeef, A; Tam, KY | 1 |
Sen, S; Sinha, N | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Alexopoulos, E; Chrisomalis, F; Karpouzas, J; Koukoudis, P; Papadimitriou, M; Papadopoulou, D; Sakellariou, G; Skenteris, N; Tsakaris, D | 1 |
Albanèse, J; Arnaud, S; Cambon, S; Miliani, Y; Rossi, P | 1 |
Halden, RU; McClellan, K; Walters, E | 1 |
Ashraf, MY; Asi, MR; Aslam, B; Javed, I; Muhammad, F; Shahzadi, A | 1 |
Chen, F; Chen, H; Fu, W; Luo, W; Meng, F; Xie, Y; Yang, X; Ye, T; Young, K | 1 |
Wang, J; Wang, JH; Wang, LJ; Zhao, X; Zhu, LS | 1 |
Chu, H; Guo, J; Yao, T; Zhang, Y; Zhou, X | 1 |
Campo, P; Dionysiou, DD; Gascó, A; Han, C; Hermosilla, D; Machala, L; Nadagouda, MN | 1 |
Gilmore, IS; Hanley, L; Pieterse, CL; Rungger, I; Wickramasinghe, RC | 1 |
Bizi, M; El Bachra, FE | 1 |
Akhdar, M; Amirzargar, AA; Esmaili, N; Firooz, A; Ghiasi, M; Khamesipour, A; Lajevardi, V; Mortazavi, H; Rostami, A; Sheykhi, I | 1 |
Alsubih, M; Balakrishnan, D; El Morabet, R; Khan, AR; Khan, NA; Khan, RA; Khan, S; Khoo, KS; Mubashir, M | 1 |
1 review(s) available for ciprofloxacin and carbamazepine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for ciprofloxacin and carbamazepine
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Plasma exchange (PE) treatment in drug-induced toxic epidermal necrolysis (TEN).
Topics: Aged; Allopurinol; Amoxicillin; Carbamazepine; Child; Ciprofloxacin; Humans; Male; Mefenamic Acid; Middle Aged; Plasma Exchange; Skin; Stevens-Johnson Syndrome; Tetanus Toxoid | 1991 |
[Severe agranulocytosis induced by carbamazepine (Tegretol)].
Topics: Acinetobacter Infections; Adult; Agranulocytosis; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Infective Agents; Carbamazepine; Ciprofloxacin; Humans; Male; Quadriplegia; Respiration, Artificial; Vancomycin | 1999 |
Occurrence and loss over three years of 72 pharmaceuticals and personal care products from biosolids-soil mixtures in outdoor mesocosms.
Topics: Antimitotic Agents; Azithromycin; Carbamazepine; Carbanilides; Ciprofloxacin; Diphenhydramine; Doxycycline; Environmental Monitoring; Fluoxetine; Sewage; Soil; Tetracycline; Thiabendazole; Triclosan | 2010 |
Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Area Under Curve; Carbamazepine; Ciprofloxacin; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Half-Life; Humans; Male; Young Adult | 2011 |
Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China.
Topics: Acetaminophen; Caffeine; Carbamazepine; Carbon; China; Ciprofloxacin; DEET; Environmental Monitoring; Erythromycin; Nitrates; Nitrites; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Quality | 2013 |
[Influence of Four Kinds of PPCPs on Micronucleus Rate of the Root-Tip Cells of Vicia-faba and Garlic].
Topics: Carbamazepine; Carbanilides; Ciprofloxacin; DNA Damage; Doxycycline; Garlic; Micronucleus Tests; Plant Roots; Vicia faba | 2016 |
The influence of four pharmaceuticals on Chlorellapyrenoidosa culture.
Topics: Carbamazepine; Catalase; Cell Culture Techniques; Chlorella; Chlorophyll A; Ciprofloxacin; Clofibric Acid; Diclofenac; Dose-Response Relationship, Drug; Lipid Metabolism; Metabolomics; Microalgae; Particle Size; Pharmaceutical Preparations; Superoxide Dismutase | 2019 |
Environmentally friendly synthesized and magnetically recoverable designed ferrite photo-catalysts for wastewater treatment applications.
Topics: Anti-Bacterial Agents; Carbamazepine; Catalysis; Ciprofloxacin; Ferric Compounds; Magnetic Phenomena; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2020 |
An Experimental and Theoretical Study of Laser Postionization of Femtosecond-Laser-Desorbed Drug Molecules.
Topics: Carbamazepine; Ciprofloxacin; Imipramine; Ions; Kinetics; Lasers; Models, Molecular; Molecular Conformation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Verapamil | 2020 |
Transport of Carbamazepine, Ciprofloxacin and Sulfamethoxazole in Activated Carbon: Solubility and Relationships between Structure and Diffusional Parameters.
Topics: Adsorption; Carbamazepine; Charcoal; Ciprofloxacin; Diffusion; Porosity; Solubility; Sulfamethoxazole; Water Pollutants, Chemical; Water Purification | 2021 |
Association between human leukocyte antigens and cutaneous adverse drug reactions to antiepileptics and antibiotics in the Iranian population.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Case-Control Studies; Ciprofloxacin; Female; Genotype; HLA Antigens; HLA-A Antigens; HLA-B Antigens; HLA-DRB1 Chains; Humans; Iran; Lamotrigine; Male; Middle Aged; Stevens-Johnson Syndrome | 2022 |
Comparison of constructed wetland performance coupled with aeration and tubesettler for pharmaceutical compound removal from hospital wastewater.
Topics: Acetaminophen; Animals; Carbamazepine; Ciprofloxacin; Erythromycin; Hospitals; Ibuprofen; Lorazepam; Pharmaceutical Preparations; Simvastatin; Waste Disposal, Fluid; Wastewater; Wetlands | 2023 |